The structure of the natural anticoagulant, heparin, is gradually being elucidated. As each step forward is made, attempts to synthesize molecules with the biological activity of heparin receive renewed impetus. It is now known (Jorpes, 1939) that heparin is composed of glucuronic acid and glucosamine though the mode of linkage of these two parts is not yet clear. Some of the hydroxyl groups of these components are esterifiedwith sulphuric acidbut the exact distribution of sulphate groups is uncertain. Recently, however, Jorpes, Bostrom & Mutt (1950) have shown that during the weak acid hydrolysis of heparin, sulphuric acid appears at the same time and with the same rate as amino groups, leading to the view that the amino group is combined with sulphuric acid. This conclusion is confirmed by the work of Meyer & Schwartz (1950) . An important contribution to our knowledge of the size of heparin molecules was made by Gronwall, Ingleman & Mosiman (1945) , who measured sedimentation and diffusion constants for a substantially purepreparationintheultracentrifuge. Sinceheparin is not absolutely homogeneous as regards molecular size it was not possible to calculate an exact value but a molecular weight of 17 000 was obtained as an average for all the molecules in the preparation.
Heparin is also inhomogeneous in respects other than molecular weight. Several mild physical methods have been employed to divide seemingly pure samples of heparin into components differing in sulphur and nitrogen content and activity. Fractional recrystallization of the brucine salt by Jorpes & Bergstrom (1937) From the facts outlined above, it appears that blood anticoagulant activity is not the property of a unique molecular configuration but is shared by a number of similar molecules occurring in the product ordinarily called heparin. An outstanding feature which has long been recognized is the neces- Biochem. 1952, 51 sity for the presence of acidic sulphate groups in molecules with anticoagulant activity. The literature contains many examples of sulphuric esters of polysaccharides exhibiting heparin-like activity in vitro. Sulphuric esters of dextran (Gronwall et at. 1945) , cellulose (Astrup & Piper, 1945a) , inulin (Ingelman, 1946) and alginic acid (Snyder) , to mention but a few, have been prepared. Usually these esters have been reported to show one-tenth to one-half of the activity of heparin in vitro, but inulin sulphuric ester is claimed to be as active as heparin in vitro.
Compounds with blood anticoagulant activity are easily prepared, but when submitted to toxicity tests some active preparations have proved fatal in doses only a few times greater than the minimum dose effective in raising the blood clotting time. Astrup & Piper (1945a, b) found that some sulphuric esters of cellulose combined with fibrinogen to form an insoluble complex. They considered such an adverse effect on fibrinogen should not occur with an anticoagulant intended for clinical use.
There appeared to be sufficient scope for systematic variation in the structure of anticoagulant molecules to enable combination with fibrinogen to be minimized while retaining a useful degree of anticoagulant activity. It seemed essential to control two factors: (1) molecular weight; (2) number of sulphate groups.
Considering first the effect of molecular weight, it is desirable to start with a polysaccharide of which the molecular weight can be subjected to controlled variation. On account of its use as a blood plasma substitute (Ingelman, 1949; Bull et al. 1949) , pure dextran is produced in large quantities and considerable attention has been given to molecular weight control (Ingelman, 1949; Ricketts, Lorenz& Maycock 1950) . Gronwall et al. (1945) describe three preparations of dextran sulphuric acid ester. Their least toxic preparation was made from dextran of relative viscosity 2 4 in 6% solution. It may be inferred from the viscosity data given by Ingelman & Halling (1949) that this dextran had a molecular weight of about 32000. The sodium salt of this dextran sulphate contained 12% sulphur, or about 1 sulphate group per glucose unit so the molecular weight of the sodium dextran sulphate would be about 9 50 000. This is about 3 times the molecular weight of heparin. However, in a subsequent paper, reporting the toxicity of an inulin sulphuric acid ester of molecular weight 14 000, Ingelman (1946) expresses the view that 'molecular weight is not a principal factor in determining toxicity'.
To resolve this point a series of sulphuric esters of dextran differing widely in molecular weight and sulphur content was prepared. The cause of their toxicity was carefully investigated and will be reported separately by Dr K. Walton.
Dextran sulphate with molecules of a certain size was found to be free from toxic effects. The relation between blood anticoagulant activity and number of sulphate groups in molecules of this size was explored.
On the basis of these experiments the preparation of dextran sulphate in a form suitable for clinical trial is reported. EXPERIMENTAL Material The starting material was dextran prepared for use as a plasma substitute (Bull et al. 1949 ). In the course of preparation the dextran of Leuconostoc mnesenteroides was partially hydrolysed by boiling with 0-075 w-H,SO, until its intrinsic viscositywas between 0-21 and 0-36. Tests to ensure freedom from toxicity and antigenicity were carried out as described by Bull et al. (1949) .
Methods
Sulphate groups were introduced by treating the finely powdered dry dextran with chlorosulphonic acid and pyridine using the proportions of reagents and conditions of Gronwall et al. (1945) , except when variations are specifically mentioned, for example in If the relation between intrinsic viscosity and molecular weight determined by Ingelman & Halling (1945) be applied to the dextran used in these experiments the average molecular weight of the dextran used for the D and E types of dextran sulphate is about 200 000 and 20 000 respectively. Allowing for the introduction of, say, 1-3 sulphate groups per glucose unit, the average molecular weight of the D and E types of dextran sulphate would be very approximately 300 000 and 30 000 respectively. The only estimate for the I type of dextran sulphate that can be obtained from the data given by Gronwall et al. (1945) is a figure of less than 20 000, allowing for the introduction of 13 sulphate groups per glucose unit. Evidence that the three types of dextran sulphate differ in average molecular weight was obtained from viscosity and osmotic pressure measurements. Viscosity was measured in 0-066 M-phosphate buffer at pH 7. Fig. 2 shows specific viscosity divided by concentration plotted against concentration for preparations D3, E 1 and I4 (see Tables 1, 3) . Extrapolation directly and using the logarithmic method mentioned by Bawn (1948) Theosmoticpressure of2 % (w/v)E l and 1% (w/v) 1 3 in 0-9 % sodium chloride solution was measured.
The solution outside the membrane was tested with toluidine blue but no metachromatic reaction was obtained in a test which was known to be sensitive to less than 10 p&g./ml. The molecular weights calculated from the equilibria were E 1, 35 000 and 1 3, 8000, but several such osmometers are necessary to provide accurate estimates of number average molecular weight. It may be inferred from these data that the molecular weight of 1 3 is considerably less than that of El. Using two osmometers and a more refined technique, Mr D. Sutcliffe has obtained a figure of 7300 + 500 for the preparation 14.
Biological testing of the preparations showed that the I series of dextran sulphates was free from toxic 0 1 2 3 4 C (g.f100 ml.) Fig. 2 . Showing direct (-) and logarithmic (---) extrapolation to obtain intrinsic viscosity of dextran sulphate preparations D3, 0E); E 1, A and 14, [].
Variation in number of 8ulphate groups Several dextran sulphates differing in sulphur content were prepared from a single batch of dextran which had an intrinsic viscosity of 0-04. Preliminary experiments indicated that alteration in the sulphur content was not achieved by decreasing the proportion of chlorosulphonic acid from 44 ml./10 g. dextran as quoted by Gronwall et al. (1945) to 14-6 ml./10 g. dextran, but was obtained between this value and 9-3 ml./10 g. dextran. isolating the product in the usual way. The relation between the number of sulphate groups per glucose unit and activity reveals a sharp increase to the maximum activity between 1 and 1X3 sulphate groups per glucose unit. For comparison, the provisional International Standard for heparin contains 12-45% sulphur in the sodium salt and has an activity of 130 units/mg. Heparin sample A contained 9-3 % S and sample B contained 8-6 % S.
Preparation of a non-toxic dextran 8ulphate
The foregoing experiments established the conditions for the preparation of an active non-toxic dextran sulphate. In view of the association of toxicity with increasing molecular weight the larger molecules were removed by fractional precipitation before introducing the sulphate groups. This precaution was intended to prevent significant amounts of toxic dextran sulphate accumulating when very large doses were given over a long period of time. A full description of the preparation of the dextran sulphate submitted to clinical trial will now be given.
To 3 1. of a 6-2 % (w/v) solution of a partial hydrolysate of L. mesenteroides dextran with intrinsic viscosity 0-25, 300 ml. N-H2504 were added and the solution boiled under reflux for 4 hr. After cooling, the solution was neutralized with w-NaOH, the final volume being 3-6 1. Acetone (31.) was added, and after standing overnight the syrupy precipitate containing the larger molecules was separated. A further 6 1. of acetone were added, the syrup was separated, poured into ethanol, ground to a powder, washed with dry ether and dried in vacuo over P.0. About 100 g. were obtained; the intrinsic viscosity was 0-02.
To 400 ml. dry pyridine, 88 ml. chlorosulphonic acid were added drop by drop with vigorous stirring. During the addition the flask was cooled in a mixture of solid CO. and ethanol. The temperature was then raised to 650 when most ofthe pyridinium salts dissolved. Finely powdered dextran, 60 g., was added and dispersed in the reaction mixture by vigorous stirring. The temperature was maintained at 65-70°for 4 hr.
After cooling, 1-51. of crushed ice and sufficient 40% (w/v) NaOH were added to turn the mixture dark red in colour and cause separation of the pyridine as an upper layer. The lower layer was diluted to 21. and brought to 370 when 21. of ethanol were added. The precipitated syrup was allowed to settle for 10 min. only at 370 to avoid crystallization of Na2SO4. The syrup was then separated, redissolved in 850 ml. water and similarly precipitated with 850 ml. of ethanol. The precipitation was repeated again from 640 ml. of solution and an equal volume of ethanol. The final syrup was dissolved in 800 ml. of water, neutralized with HCI, dialysed against running water and treated with charcoal at 500. The pH of the filtrate was adjusted to 7-7-5 with NaOH and the solution concentrated under reduced pressure to 500 ml. Acetone (750 ml.) was added, and the precipitated syrup was poured into ethanol, ground to a powder, washed with ether and dried in vacuo over P205. This preparation was designated 13. Details of this and a number of similar preparations are summarized in Table 3 .
Dextran sulphates of the I series decompose on boiling in aqueous solution with the formation of inorganic sulphate and reducing substances, a point of some importance in connexion with the sterilization of solutions for intravenous administration. For example, after autoclaving a neutral 20 % (w/v) solution of I4 at 10 lb. steam pressure for 20 min., one-third of the sulphur was liberated as sulphuric acid and the solution was found to reduce Fehling's reagent strongly. Some of the dextran sulphate which had not decomposed was recovered and found to contain 13-5 S and to be about as active as 1 4.
It was found that this decomposition could be prevented by buffering the solution. The following mixture has proved satisfactory: dextran sulphate, 20 g.; sodium chloride, 0-72 g.; sodium bicarbonate, 0-24 g.; water, 100 ml. A solution of this composition had an initial pH of 8-3, and was autoclaved at 10 lb. for 10 min. without the appearance of inorganic sulphate or reducing substances, and without appreciable loss of activity. It is therefore important to consider the evidence relating to the molecular weight of the three types of dextran sulphate preparation used in the biological investigation. The intrinsic viscosity of the dextrans and of the dextran sulphates derived from them indicate corresponding differences in molecular weight. The critical distinction in toxicity is between the E type and the I type and here the osmotic pressures recorded support the contention that the I type is of considerably lower molecular weight than the E type, being of the order of 7000.
The anticoagulant activity expressed in units/mg. appears to be independent of the molecular weight but depends on a certain minimum number of sulphate groups per glucose unit. At 10-13 sulphate groups per glucose unit the sharp increase of activity to its maximum value is indicative ofthe appearance of some critical pattern of groups in the molecular structure. Heparin has greater activity with considerably fewer sulphate groups in the molecule. From the biological investigations evidence was obtained that the activity of heparin and dextran sulphate was qualitatively identical, in spite of the sevenfold difference in the weight corresponding with a given amount of anticoagulant activity. STJMMARY 1. Molecular weight determines the toxicity of dextran sulphate. Molecules smaller than a critical size are not toxic.
2. Maximum blood anticoagulant activity is attained when the number of sulphate groups exceeds an average of 1-3 per glucose unit.
3. Preparation of a potentially useful anticoagulant drug is described.
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